TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06380361

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BioSpy System
Description: One arm only - in all eligible study patients, the study device will be used. In patients with suspicion of lung cancer a bronchoscope will be inserted to navigate to the lesion where a biopsy sample will be taken for histology analysis. In the current trial, the device will be used to perform electrophysiological measurements in the lesion during bronchoscopic biopsy procedure.
Study: NCT06349330

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Test: 3D intra-oral scanner
Description: 3D intra-oral scanner will be used to scan the subjects after plaque staining is performed. Subsequently, a 3D rendered image will be produced. Participants will be given oral hygiene education and instruction before being instructed to brush.~A cooling-off period of 30 minutes is given before participants are instructed to brush.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control: Standard oral hygiene
Description: Standard oral hygiene instructions will be delivered using a hand mirror. No 3D intraoral scanner will be used.
Study: NCT06556446

Intervention type: DRUG
Intervention: Tenecteplase and Alteplase
Description: The timepoints, dose, and type of IVT will be collected as well as any complications occuring.
Study: NCT04967144

Intervention type: DIAGNOSTIC_TEST
Intervention: Nerve conduction study
Description: Participants with carpal tunnel syndrome will consist of individuals whose diagnosis has been confirmed by an electrophysiological study.~Participants in the control group will consist of those who have been confirmed not to have carpal tunnel syndrome by nerve conduction study.

Intervention type: DIAGNOSTIC_TEST
Intervention: Nerve conduction study
Description: Participants with carpal tunnel syndrome will consist of individuals whose diagnosis has been confirmed by an electrophysiological study.~Participants in the control group will consist of those who have been confirmed not to have carpal tunnel syndrome by nerve conduction study.

Intervention type: DIAGNOSTIC_TEST
Intervention: Montreal Cognitive Assessment Test
Description: Montreal Cognitive Assessment Test evaluates eight separate cognitive functions. Thirty is the highest score. The scores equal to or above 26 are considered normal cognitive function.

Intervention type: DIAGNOSTIC_TEST
Intervention: Montreal Cognitive Assessment Test
Description: Montreal Cognitive Assessment Test evaluates eight separate cognitive functions. Thirty is the highest score. The scores equal to or above 26 are considered normal cognitive function.
Study: NCT06046885

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation
Description: As regards the electrodes position, one proximal electrode on the gastrocnemius, which will be located below the popliteal fossa (at least 5cm below it) for a better position on the muscle belly; and one distal electrode, located at least 10 cm from the calcaneus.~This protocol will last 20 minutes per session. The placement of the electrodes is as mentioned above, and the parameters to be used will be the following: a stimulation frequency between 35 and 80Hz, a pulse width between 150 and 200 µs, the intensity will be established individually using an intensity that generate a visible contraction of maximum intensity without generating pain. The duration of the contraction will be of 6 seconds with 30 seconds of rest.
Study: NCT06350396

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: active rTMS treatment
Description: Participants will receive 3 sessions per day of 1800 pulses per session, lasting for 21 days. Individualized targets will be generated using the pBFS method.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham rTMS treatment
Description: The parameters in the sham arms are the same as the active stimulation groups. Stimulation was delivered by the same device as the active group fitted with a sham coil.
Study: NCT06192784

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: DEB-TACE
Description: transcatheter arterial chemoembolization with doxorubicin embedded eluting beads- was performed every 3 weeks through the tumor feeding arteries.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib plus pucotenlimab
Description: lenvatinib (8mg, qd) plus pucotenlimab (200mg, q3w)
Study: NCT06007339

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PerQseal ELITE
Description: The term PerQseal Elite used singularly refers to the closure system comprising the closure device and Introducer. These individually are referred to as: PerQseal Elite VCD or PerQseal Elite closure device and/or PerQseal Elite Introducer.
Study: NCT05246683

Intervention type: OTHER
Intervention: observational
Description: registry
Study: NCT05667792

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Microsoft Kinect 360
Description: Balance and trunk proprioception games will be selected and played for the children to be included in the treatment. Children will play these games with their own body movements.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Microsoft Kinect 360
Description: Balance and trunk proprioception games will be selected and played for the children to be included in the treatment. Children will play these games with their own body movements.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Pediatric Rehabilitation
Description: Bobath therapy

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Pediatric Rehabilitation
Description: Bobath therapy

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pediatric Rehabilitation
Description: Bobath therapy

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pediatric Rehabilitation
Description: Bobath therapy
Study: NCT04982952

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Contingency Management - Increasing
Description: Increasing incentive payment for abstinent participant
Study: NCT05161819

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation
Description: High-frequency stimulation (10Hz), 120% motor threshold, 40 trains, 1600 pulses

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham stimulation
Description: High-frequency stimulation (10Hz), 120% motor threshold, 40 trains, 1600 pulses (with sham coil)
Study: NCT04982952

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Fixed payments
Description: Fixed payments for attending study visits
Study: NCT05228275

Intervention type: PROCEDURE
Intervention: Biospecimen Collection
Description: Undergo collection of blood samples

Intervention type: OTHER
Intervention: Survey Administration
Description: Complete survey
Study: NCT04641221

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Weekly Yoga Classes
Description: All participants are invited to attend weekly yoga classes.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Weekly Yoga Classes
Description: All participants are invited to attend weekly yoga classes.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Weekly Yoga Classes
Description: All participants are invited to attend weekly yoga classes.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Weekly Yoga Classes
Description: All participants are invited to attend weekly yoga classes.
Study: NCT05334680

Intervention type: DEVICE
Intervention: ANNE Sensor
Description: The data collected from this sensor contains a wide range of core and novel respiratory digital biomarkers as a home-based early identification system. The core measurements include: heart rate, heart rate variability, temperature, physical activity (including sleep quality) and respiratory rate. The novel respiratory digital biomarkers include: respiratory cadence (expiration / inspiration time), coughing, swallowing, throat clearing, and talk time.

Intervention type: DEVICE
Intervention: ANNE Sensor
Description: The data collected from this sensor contains a wide range of core and novel respiratory digital biomarkers as a home-based early identification system. The core measurements include: heart rate, heart rate variability, temperature, physical activity (including sleep quality) and respiratory rate. The novel respiratory digital biomarkers include: respiratory cadence (expiration / inspiration time), coughing, swallowing, throat clearing, and talk time.
Study: NCT05481203

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The Kaleidescope
Description: During the nasopharyngeal swab collection process, the researcher held a kaleidoscope to each child's eye, leisurely turning it and asking about the colors and shapes seen within it.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The visual illusion cards
Description: Just before the nasopharyngeal swab participants were allowed to check the cards andwere askedwhat they saw in them.
Study: NCT05726019

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Colchicine
Description: Oral tablet colchicine 0.5mg, twice a day, will be started within 24 hours after randomization and maintained until 30 days after coronary artery bypass grafting.
Study: NCT04850703

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Radom Noise Stimulation
Description: tRNS against Dapoxetine in LPE patients

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Take Dapoxetine
Description: Dapoxetine against tRNS in LPE patients

Intervention type: COMBINATION_PRODUCT
Group type: SHAM_COMPARATOR
Intervention: Comparation EEG changes between Sham Group against tRNS and Dapoxetin participants
Description: Compare EEG parameters like Theta Rhythm and Coherence between three groups of participants: sham, tRNS participants and Dapoxetine participants groups.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Compare LPE EEG endophenotype between participants and healthy controls
Description: Define as precisely as possible the electrophysiological endophenotype of Longlife Premature Ejaculation, using healthy humans who do not express the LPE EEG endophenotype
Study: NCT04641221

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Weekly Yoga Classes
Description: All participants are invited to attend weekly yoga classes.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Weekly Yoga Classes
Description: All participants are invited to attend weekly yoga classes.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Weekly Yoga Classes
Description: All participants are invited to attend weekly yoga classes.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Weekly Yoga Classes
Description: All participants are invited to attend weekly yoga classes.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Weekly Yoga Classes
Description: All participants are invited to attend weekly yoga classes.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Weekly Yoga Classes
Description: All participants are invited to attend weekly yoga classes.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Weekly Yoga Classes
Description: All participants are invited to attend weekly yoga classes.
Study: NCT05157451

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality of Life
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality of Life
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy
Description: Undergo SBRT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Yttrium-90 Microsphere Radioembolization
Description: Given via injection
Study: NCT06128590

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Photobiomodulation
Description: Photobiomodulation was applied before the procedures at an infrared wavelength of 808nm, at a power of 100mW, 1 point with a total energy of 8J, time of 80s, irradiance of 3.33W/cm² and radiant exposure of 266.66 J/cm2. The application point was on the retromolar region where the needle was inserted to perform the anesthetic, in a single application before the procedure.~The patient and operator were properly protected with goggles in both the control and experimental groups.

Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Mepivacaine hydrochloride in combination with epinephrine
Description: The anesthetic of choice will be Mepivacaine, which is widely used in dentistry with duration between 1.5 and 2 minutes. The maximum recommended dose is 6.6 mg/Kg, not exceeding 400 mg or 11 anesthetic tubes.~It is a sterile injectable solution of 2% mepivacaine hydrochloride (20 mg/mL) in combination with epinephrine 1:100,000 (0.01 mg/mL). Each vial contains 1.8 mL, 36 mg of mepivacaine hydrochloride, and 0.018 mg of epinephrine. All patients will use anesthetics from the same brand (DLA Pharmaceutical LTDA), one of the most widely used on the market. All patients will be anesthetized with tubes from the same batch, one tube per procedure.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mepivacaine hydrochloride in combination with epinephrine
Description: The anesthetic of choice will be Mepivacaine, which is widely used in dentistry with duration between 1.5 and 2 minutes. The maximum recommended dose is 6.6 mg/Kg, not exceeding 400 mg or 11 anesthetic tubes.~It is a sterile injectable solution of 2% mepivacaine hydrochloride (20 mg/mL) in combination with epinephrine 1:100,000 (0.01 mg/mL). Each vial contains 1.8 mL, 36 mg of mepivacaine hydrochloride, and 0.018 mg of epinephrine. All patients will use anesthetics from the same brand (DLA Pharmaceutical LTDA), one of the most widely used on the market. All patients will be anesthetized with tubes from the same batch, one tube per procedure.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Photobiomodulation simulation
Description: The participants will be treated in the same manner as in group A. The person responsible for the application of FBM will simulate the irradiations by placing the device in the same location described for the experimental group, but the equipment will remain turned off. To prevent the participant from identifying their group, the activation sounds of the devices (beeps) will be recorded to simulate the device's operation.
Study: NCT04649073

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: OPC-415
Description: OPC-415 (up to 1×10\^7cells/kg) On 2 days
Study: NCT05494541

Intervention type: OTHER
Intervention: Crizanlizumab
Description: Patients who initiated crizanlizumab between November 1, 2019 and January 31, 2021 (index period) were selected into the treatment cohort.

Intervention type: OTHER
Intervention: Crizanlizumab
Description: Patients who initiated crizanlizumab between November 1, 2019 and January 31, 2021 (index period) were selected into the treatment cohort.

Intervention type: OTHER
Intervention: Crizanlizumab
Description: Patients who initiated crizanlizumab between November 1, 2019 and January 31, 2021 (index period) were selected into the treatment cohort.
Study: NCT04641221

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Weekly Yoga Classes
Description: All participants are invited to attend weekly yoga classes.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Weekly Yoga Classes
Description: All participants are invited to attend weekly yoga classes.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Weekly Yoga Classes
Description: All participants are invited to attend weekly yoga classes.
Study: NCT06554028

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: chemotherapy TP regimen combined with Tislelizumab
Description: Induction chemotherapy TP regimen combined with Tislelizumab for 3 cycles: Cisplatin 37.5mg/m2 d1-2 q3w, Docetaxel 37.5mg/m2 d1and d3 q3w,Tislelizumab 200mg d3 q3w.~•Response rate of primary tumor or lymph nodes is evaluated using laryngoscopy and head and neck MRI after 3 cycles of induction therapy. If the primary lesion reaches CR/PR and the lymph nodes reach CR, chemoradiotherapy based on cisplatin is conducted. If the primary lesion reaches CR/PR and lymph node PR/PD, cervical lymph node dissection will be performed, followed by radiotherapy/concurrent chemoradiotherapy. If the primary lesion is SD/PD, regardless of the condition of the lymph nodes, primary lesion resection and lymph node dissection should be performed, followed by adjuvant radiation/chemoradiation.~Other Names:~Docetaxel Cisplatin Paclitaxel
Study: NCT04641221

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Weekly Yoga Classes
Description: All participants are invited to attend weekly yoga classes.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Weekly Yoga Classes
Description: All participants are invited to attend weekly yoga classes.
Study: NCT06168396

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Somatosensation Device
Description: The somatosensation device will be worn on the lower limb (either the residual limb for an amputee, or limb with decreased sensation for a participant with diabetic neuropathy) while performing outcome measures.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Baseline
Description: Participants will perform outcome measures without wearing the somatosensation device.
Study: NCT05497375

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: The amount of intraoperative bleeding
Description: Total amount of intraoperative bleeding will be calculated in milliliters after the end of surgery.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: The amount of intraoperative bleeding
Description: Total amount of intraoperative bleeding will be calculated in milliliters after the end of surgery.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Quality of the intraoperative surgical field
Description: Quality of the intraoperative surgical field will be measured on a grade of 0-10 (0-1. no bleeding, 2-3. mild bleeding, 4-5. Mild to moderate bleeding, 6-7. moderate bleeding, 8-9. moderate to severe bleeding, 10. Severe bleeding)

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Quality of the intraoperative surgical field
Description: Quality of the intraoperative surgical field will be measured on a grade of 0-10 (0-1. no bleeding, 2-3. mild bleeding, 4-5. Mild to moderate bleeding, 6-7. moderate bleeding, 8-9. moderate to severe bleeding, 10. Severe bleeding)

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Surgeon Satisfaction
Description: Surgeon Satisfaction will be measured on a grade of 0-5 (1= very bad, 2= bad, 3= moderate, 4= good, 5= very good).

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Surgeon Satisfaction
Description: Surgeon Satisfaction will be measured on a grade of 0-5 (1= very bad, 2= bad, 3= moderate, 4= good, 5= very good).

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Heart rate
Description: From beginning of Anesthesia induction to the end of anesthesia (during perioperative period)

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Heart rate
Description: From beginning of Anesthesia induction to the end of anesthesia (during perioperative period)

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Mean arterial pressure
Description: From beginning of Anesthesia induction to the end of anesthesia (during perioperative period)

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Mean arterial pressure
Description: From beginning of Anesthesia induction to the end of anesthesia (during perioperative period)

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Peripheral oxygen saturation
Description: From beginning of Anesthesia induction to the end of anesthesia (during perioperative period)

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Peripheral oxygen saturation
Description: From beginning of Anesthesia induction to the end of anesthesia (during perioperative period)
Study: NCT05499702

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Caloric Restriction
Description: Subjects will be instructed to consume a diet of 900 kcal daily using meals derived from Nutritional Guidelines after Bariatric Surgery. Compliance will be monitored by weekly meetings with the dietician using an electronic record of food intake

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyperglycemic clamp
Description: Hyperglycemic clamp to measure the effect of glucagon on hepatic metabolism
Study: NCT06262893

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Shoulder arthroscopy blocks
Description: Effect of dexamethasone adjuvant in combined supraclavicular block and suprascapular block versus Interscalene block in patients undergoing shoulder arthroscopy.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Shoulder arthroscopy blocks
Description: Effect of dexamethasone adjuvant in combined supraclavicular block and suprascapular block versus Interscalene block in patients undergoing shoulder arthroscopy.
Study: NCT03382249

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Sonodynamic therapy (SDT)
Description: Sonodynamic therapy(SDT) treatment is the combination of sonosensitizer administration and target atherosclerotic lesions ultrasound exposure. Sinoporphyrin sodium (DVDMS) as sonosensitizer, is dissolved in 0.9% sodium solution for following skin test and intravenous injection. 0.01mg/ml DVDMS solution (0.1ml) is prepared for skin test followed by 0.04 mg/ml DVDMS solution intravenous injection (0.2mg/kg).The target atherosclerotic lesions are marked on the corresponding skin with ultrasound guidance and underwent ultrasound exposure after 4 hours incubation. The therapeutic ultrasonic transducer is fixed to the marked skin site for 15min of each lesion. Ultrasound parameters included intensity of 1.6W/cm2 for carotid lesions, resonance frequency: 1.0 MHz and duty factor: 30%.

Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: pseudo-SDT
Description: Pseudo-SDT combines saline injection and obstructed ultrasound exposure on targeted lesions to simulate real SDT progression.
Study: NCT04882982

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Caria app
Description: App to improve symptoms of menopause

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Menopause Education
Description: Educational materials about symptoms of menopause